Virtus ETF Advisers’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $61.1K | Buy |
|
|||||
|
2024
Q3 | $73K | Buy |
|
|||||
|
2024
Q2 | $78K | Buy |
|
|||||
|
2024
Q1 | $74.8K | Sell |
|
|||||
|
2023
Q4 | $88.6K | Buy |
|
|||||
|
2023
Q3 | $69.3K | Sell |
|
|||||
|
2023
Q2 | $98.1K | Sell |
|
|||||
|
2023
Q1 | $97.3K | Sell |
|
|||||
|
2022
Q4 | $126K | Buy |
|
|||||
|
2022
Q3 | $152K | Buy |
|
|||||
|
2022
Q2 | $139K | Buy |
|
|||||
|
2022
Q1 | $98K | Sell |
|
|||||
|
2021
Q4 | $168K | Sell |
|
|||||
|
2021
Q3 | $325K | Sell |
|
|||||
|
2021
Q2 | $412K | Sell |
|
|||||
|
2021
Q1 | $462K | Buy |
|
|||||
|
2020
Q4 | $308K | Sell |
|
|||||
|
2020
Q3 | $317K | Sell |
|
|||||
|
2020
Q2 | $380K | Buy |
|